Scromiting: The Cannabis-Linked Syndrome Alarming Emergency Rooms

Scromiting, a rapidly rising medical concern, is drawing global attention as emergency departments report increasing cases linked to long-term cannabis use. Recently recognised by major health bodies, this condition highlights a growing public health challenge as cannabis consumption becomes more frequent worldwide.

Understanding the Disorder

‘Scromiting’ is an informal term coined by emergency room staff to describe the severe combination of screaming and vomiting displayed by some chronic cannabis users. Medically, it is known as cannabinoid hyperemesis syndrome (CHS). The condition involves repeated bouts of uncontrollable vomiting, intense abdominal pain, and debilitating nausea that can persist for hours or days.

Formal Recognition by Global Health Agencies

The World Health Organization has now formally acknowledged CHS, adding it to the International Classification of Diseases. It is listed under ICD-10 as R11.16 and under ICD-11 as DD90.4. This formal coding allows authorities to track its prevalence accurately and monitor the growing health burden associated with rising cannabis use. The US Centers for Disease Control and Prevention has also adopted the classification for nationwide surveillance.

Why Long-Term Cannabis Use Triggers CHS

Current research indicates that prolonged and intense cannabis consumption is the primary driver of scromiting. A study from George Washington University found that patients with CHS often experience cyclical symptoms leading to repeat hospital visits. Many users were unaware that cannabis itself was the cause. Another 2025 study by Arizona State University found that illicit cannabis contaminated with Fusarium mycotoxins may worsen vomiting symptoms, potentially intensifying CHS in frequent users.

Exam Oriented Facts

• Scromiting is the colloquial term for cannabinoid hyperemesis syndrome.
• CHS is officially listed in ICD-10 (R11.16) and ICD-11 (DD90.4).
• Long-term or daily cannabis use is the main risk factor for CHS.
• Mycotoxin contamination in illicit cannabis may aggravate symptoms.

Rising Public Health Impact

Surveys of affected individuals show high rates of emergency visits and hospitalisation, particularly among daily users or those who begin cannabis use early in life. Clinicians are urged to inform frequent users about the risks and provide support for cessation. With rising cannabis availability and potency, scromiting is increasingly seen as a hidden but significant health threat requiring sustained medical awareness and public education.